BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22504573)

  • 1. Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients.
    Li Y; Hu X; Cai B; Chen J; Bai Y; Tang J; Liao Y; Wang L
    Transpl Immunol; 2012 Aug; 27(1):12-8. PubMed ID: 22504573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis.
    Liu YY; Li C; Cui Z; Fu X; Zhang S; Fan LL; Ma J; Li G
    Gene; 2013 Dec; 531(2):476-88. PubMed ID: 24042126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
    Li D; Gui R; Li J; Huang Z; Nie X
    Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tada H; Tsuchiya N; Satoh S; Kagaya H; Li Z; Sato K; Miura M; Suzuki T; Kato T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1730-2. PubMed ID: 15919447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
    Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between MDR1 gene polymorphism and blood concentration of tacrolimus in renal transplant patients].
    Wang W; Zhang XD; Ma LL; Lü YP; Hu XP; Zhang P; Wang Y; Guan DL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3277-81. PubMed ID: 16409819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
    Akbas SH; Bilgen T; Keser I; Tuncer M; Yucetin L; Tosun O; Gultekin M; Luleci G
    Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients.
    Ciftci HS; Ayna TK; Caliskan YK; Guney I; Bakkaloglu H; Nane I; Aydin AE; Turkmen A; Gurtekin M
    Transplant Proc; 2013 Apr; 45(3):895-900. PubMed ID: 23622581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients.
    Tirelli S; Ferraresso M; Ghio L; Meregalli E; Martina V; Belingheri M; Mattiello C; Torresani E; Edefonti A
    Med Sci Monit; 2008 May; 14(5):CR251-254. PubMed ID: 18443548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the effect of MDR1 C3435T polymorphism on cyclosporine pharmacokinetics.
    Jiang ZP; Wang YR; Xu P; Liu RR; Zhao XL; Chen FP
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):433-44. PubMed ID: 18801030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
    Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L; Aguilera-García I; Docobo-Pérez F; Alamo-Martínez JM; Pareja-Ciuró F; Nuñez-Roldán A; Gómez-Bravo MA; Bernardos-Rodríguez A
    Transplant Proc; 2008 Nov; 40(9):2949-51. PubMed ID: 19010156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.
    Chakkera HA; Chang YH; Bodner JK; Behmen S; Heilman RL; Reddy KS; Mulligan DC; Moss AA; Khamash H; Katariya N; Hewitt WR; Pitta TL; Frassetto LA
    Transplant Proc; 2013; 45(1):137-41. PubMed ID: 23375287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism.
    Zheng H; Zeevi A; Schuetz E; Lamba J; McCurry K; Griffith BP; Webber S; Ristich J; Dauber J; Iacono A; Grgurich W; Zaldonis D; McDade K; Zhang J; Burckart GJ
    J Clin Pharmacol; 2004 Feb; 44(2):135-40. PubMed ID: 14747421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.
    Korkor MS; El-Desoky T; Mosaad YM; Salah DM; Hammad A
    Ital J Pediatr; 2023 May; 49(1):57. PubMed ID: 37198710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients.
    Foote CJ; Greer W; Kiberd B; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplantation; 2007 May; 83(10):1380-4. PubMed ID: 17519790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of MDR1 gene polymorphisms for tacrolimus dosage.
    Kravljaca M; Perovic V; Pravica V; Brkovic V; Milinkovic M; Lausevic M; Naumovic R
    Eur J Pharm Sci; 2016 Feb; 83():109-13. PubMed ID: 26705892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus.
    Vafadari R; Bouamar R; Hesselink DA; Kraaijeveld R; van Schaik RH; Weimar W; Baan CC; van Gelder T
    Ther Drug Monit; 2013 Aug; 35(4):459-65. PubMed ID: 23743668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.